Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2018, Article ID 7041576, 4 pages
https://doi.org/10.1155/2018/7041576
Case Report

A Rare but Fascinating Disorder: Case Collection of Patients with Schnitzler Syndrome

1Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
2Division of Rheumatology, Department of Medicine, University of Iowa, Iowa City, IA 52242, USA

Correspondence should be addressed to Maaman Bashir; moc.liamg@rihsabnamaam

Received 26 September 2017; Revised 16 January 2018; Accepted 8 February 2018; Published 8 March 2018

Academic Editor: Mehmet Soy

Copyright © 2018 Maaman Bashir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. de Koning, “Schnitzler’s syndrome: lessons from 281 cases,” Clinical and Translational Allergy, vol. 4, no. 1, p. 41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Sokumbi, L. A. Drage, and M. S. Peters, “Clinical and histopathologic review of Schnitzler syndrome: The Mayo Clinic experience (1972–2011),” Journal of the American Academy of Dermatology, vol. 67, no. 6, pp. 1289–1295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Barriere, L. Schnitzler, G. Moulin, and Y. Grolleau, “Chronic urticarial lesions and macroglobulinemia. Apropos of 5 cases,” La Semaine des Hôpitaux, vol. 52, pp. 221–227, 1976. View at Google Scholar
  4. A. Simon, B. Asli, M. Braun-Falco et al., “Schnitzler’s syndrome: diagnosis, treatment, and follow-up,” Allergy, vol. 68, no. 5, pp. 562–568, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Kieffer, B. Cribier, and D. Lipsker, “Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease: report of 9 new cases and review of the literature,” Medicine, vol. 88, no. 1, pp. 23–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Krause, E. Feist, M. Fiene, T. Kallinich, and M. Maurer, “Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome,” Journal of Allergy and Clinical Immunology, vol. 129, no. 3, pp. 848–850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Lipsker, D. Spehner, R. Drillien et al., “Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions,” British Journal of Dermatology, vol. 142, no. 5, pp. 954–959, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. H. D. de Koning, E. J. Bodar, and J. W. van der Meer, “Schnitzler syndrome study group. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment,” Seminars in Arthritis and Rheumatism, vol. 37, no. 3, pp. 137–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Lipsker, Y. Veran, F. Grunenberger, B. Cribier, E. Heid, and E. Grosshans, “The Schnitzler syndrome. Four new cases and review of the literature,” Medicine, vol. 80, no. 1, pp. 37–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. D. De Koning, M. E. Van Gijn, M. Stoffels et al., “Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome,” Journal of Allergy and Clinical Immunology, vol. 135, no. 2, pp. 561–564, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Guo, J. Gao, D. J. Taxman et al., “HIV-1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes,” Journal of Biological Chemistry, vol. 289, no. 31, pp. 21716–21726, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Briken, S. E. Ahlbrand, and S. Shah, “Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship,” Frontiers in Cellular and Infection Microbiology, vol. 3, p. 62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Noster, H. D. de Koning, E. Maier et al., “Dysregulation of proinflammatory versus anti-inflammatory human TH17 cell functionalities in the autoinflammatory Schnitzler syndrome,” Journal of Allergy and Clinical Immunology, vol. 138, no. 4, pp. 1161–1169, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kolivras, A. Theunis, A. Ferster et al., “Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement,” Journal of Cutaneous Pathology, vol. 38, pp. 202–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. D. De Koning, J. Schalkwij, J. Van der Ven-Jongerkriig et al., “Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler’s syndrome,” Annals of the Rheumatic Diseases, vol. 72, no. 10, pp. 1634–1638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Vanderschueren and D. Knockaert, “Canakinumab in Schnitzler syndrome,” Seminars in Arthritis and Rheumatism, vol. 42, no. 4, pp. 413–416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Pesek and R. Fox, “Successful treatment of Schnitzler syndrome with canakinumab,” Cutis, vol. 94, pp. E11–E12, 2014. View at Google Scholar
  18. K. Krause, K. Weller, R. Stefaniak et al., “Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study,” Allergy, vol. 67, no. 7, pp. 943–950, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Krause, A. Tsianakas, N. Wagner et al., “Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study,” Journal of Allergy and Clinical Immunology, vol. 139, no. 4, pp. 1311–1320, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Lipsker, “The Schnitzler syndrome,” Orphanet Journal of Rare Diseases, vol. 5, no. 1, p. 38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Asli, J. C. Brouet, and J. P. Fernand, “Spontaneous remission of Schnitzler syndrome,” Annals of Allergy, Asthma & Immunology, vol. 107, no. 1, pp. 87-88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Gusdorf and D. Lipsker, “Schnitzler syndrome: a review,” Current Rheumatology Reports, vol. 19, no. 8, p. 46, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Tinazzi, A. Puccetti, G. Patuzzo, M. Sorleto, A. Barbieri, and C. Lunardi, “Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature,” Autoimmunity Reviews, vol. 10, no. 7, pp. 404–409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Kyle, T. M. Therneau, S. V. Rajkumar et al., “Long-term follow-up of IgM monoclonal gammopathy of undetermined significance,” Blood, vol. 102, no. 10, pp. 3759–3764, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Lim, K. H. Shumak, M. Reis et al., “Malignant evolution of Schnitzler’s syndrome: chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature,” Leukemia & Lymphoma, vol. 43, no. 1, pp. 181–186, 2002. View at Publisher · View at Google Scholar · View at Scopus